Literature DB >> 35989978

The Canadian Liver Meeting is a collaborative effort of the Canadian Association for the Study of the Liver (CASL), the Canadian Network on Hepatitis C (CANHEPC) and the Canadian Association of Hepatology Nurses (CAHN).

.   

Abstract

Entities:  

Year:  2018        PMID： 35989978      PMCID： PMC9202676     

Source DB:  PubMed          Journal:  Can Liver J        ISSN： 2561-4444


× No keyword cloud information.
  16 in total

1.  Physicians' attitudes and practice toward treating injection drug users with hepatitis C: results from a national specialist survey in Canada.

Authors:  Angelique Myles; Gerry J Mugford; Jing Zhao; Murray Krahn; Peizhong P Wang
Journal:  Can J Gastroenterol       Date:  2011-03       Impact factor: 3.522

2.  Risk environments and drug harms: a social science for harm reduction approach.

Authors:  Tim Rhodes
Journal:  Int J Drug Policy       Date:  2009-01-14

3.  Hepatitis C Management and the Infectious Diseases Physician: A Survey of Current and Anticipated Practice Patterns.

Authors:  Cody A Chastain; Susan E Beekmann; Erika K Wallender; Todd Hulgan; Jack T Stapleton; Philip M Polgreen
Journal:  Clin Infect Dis       Date:  2015-05-15       Impact factor: 9.079

4.  Peripartum cytokine flares in a multiethnic cohort of chronic hepatitis B carriers does not correlate with hepatitis B virus suppression or increased risk of liver disease.

Authors:  Shivali S Joshi; Daniel Wong; Eliana Castillo; Mark G Swain; Carla S Coffin
Journal:  Am J Reprod Immunol       Date:  2017-05-19       Impact factor: 3.886

5.  Variation between Canadian centres in the uptake of treatment for hepatitis C by patients coinfected with HIV: a prospective cohort study.

Authors:  Jim Young; Martin Potter; Joseph Cox; Curtis Cooper; John Gill; Mark Hull; Sharon Walmsley; Marina B Klein
Journal:  CMAJ Open       Date:  2013-09-24

Review 6.  Burden of disease and cost of chronic hepatitis C infection in Canada.

Authors:  Robert P Myers; Mel Krajden; Marc Bilodeau; Kelly Kaita; Paul Marotta; Kevork Peltekian; Alnoor Ramji; Chris Estes; Homie Razavi; Morris Sherman
Journal:  Can J Gastroenterol Hepatol       Date:  2014-05

7.  Clinical proteomics for liver disease: a promising approach for discovery of novel biomarkers.

Authors:  Hirofumi Uto; Shuji Kanmura; Yoichiro Takami; Hirohito Tsubouchi
Journal:  Proteome Sci       Date:  2010-12-31       Impact factor: 2.480

8.  The Population Level Cascade of Care for Hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC).

Authors:  Naveed Z Janjua; Margot Kuo; Amanda Yu; Maria Alvarez; Stanley Wong; Darrel Cook; Jason Wong; Jason Grebely; Zahid A Butt; Hasina Samji; Alnoor Ramji; Mark Tyndall; Mel Krajden
Journal:  EBioMedicine       Date:  2016-08-25       Impact factor: 8.143

9.  A Hepatitis C Educational Needs Assessment of Canadian Healthcare Providers.

Authors:  Reza Naghdi; Karen Seto; Carolyn Klassen; Didi Emokpare; Brian Conway; Melissa Kelley; Eric Yoshida; Hemant A Shah
Journal:  Can J Gastroenterol Hepatol       Date:  2017-03-15

10.  Mother-to-child transmission of hepatitis B virus in sub-Saharan Africa: time to act.

Authors:  Monique I Andersson; Ruma Rajbhandari; Michael C Kew; Sandro Vento; Wolfgang Preiser; Andy I M Hoepelman; Gerhard Theron; Mark Cotton; Jennifer Cohn; Dieter Glebe; Olufunmilayo Lesi; Mark Thursz; Marion Peters; Raymond Chung; Charles Wiysonge
Journal:  Lancet Glob Health       Date:  2015-07       Impact factor: 26.763
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.